Eddid Financial Receives In-Principle Approval for Singapore Capital Markets Services License
Eyes Southeast Asian Expansion HONG KONG, Nov. 29, 2024 /PRNewswire/ -- Eddid Financial (the "Group"), an all-encompassing financial group, announced that its wholly-owned subsidiary in Singapore, Eddid Financial Singapore Pte. Ltd., has received...
Appointment of New Director General for The Chartered Governance Institute
HONG KONG, Nov. 29, 2024 /PRNewswire/ -- Today, CGI Global, the Chartered Governance Institute, the premier global qualifying body for Chartered Secretaries and Chartered Governance Professionals, announced the appointment of Kerrie Waring to lead...
MINISO Group Announces September Quarter and First Nine Months of 2024 Unaudited Financial Results
GUANGZHOU, China, Nov. 29, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today...
Oxford's Big Data Pioneer Inspires Students at Concordia Shanghai
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Concordia International School Shanghai had the honor of welcoming world-renowned scholar and "father of big data," Professor Viktor Mayer-Schönberger, to campus this November. The Oxford professor delivered a...
Metalpha Appoints New CFO
HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Metalpha Technology Holding Limited (Nasdaq: MATH) (the "Company" or "Metalpha"), a global digital asset-focused wealth management company, today announced the appointment of Mr. Pengyuan Fan as Chief...
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage...
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage...
iQOO 13 unleashes the full potential of Snapdragon® 8 Elite with joint tuning for the ultimate mobile experience
Simultaneously supported by iQOO ' s Q2 chip, iQOO 13 raises the performance bar with advanced speed, stability, imaging, and cooling for mobile users who expect more. DONGGUAN, China, Nov. 28, 2024 /PRNewswire/ -- iQOO, an independent sub-brand of...
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...
Xinhua Silk Road: Multiple achievements made at promotion conference held in Shanghai
BEIJING, Nov. 28, 2024 /PRNewswire/ -- A series of achievements was recently made at the Shanghai Jing'an "Global Service Provider Program" (GSPP) Promotion Conference and the 1st China Enterprise Globalization Development Professional Service...